The anti-catabolic effects of n-3 fatty acids

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 2, Issue 3, 1999, Pages 219-226

  Ross, James A ^a   Moses, Alastair G W ^a   Fearon, Kenneth C H ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; OMEGA 3 FATTY ACID;

ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENETICS; HUMAN; MEMBRANE FLUIDITY; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EICOSANOIDS; FATTY ACIDS, OMEGA-3; HUMANS; MEMBRANE FLUIDITY; METABOLISM; SIGNAL TRANSDUCTION;

EID: 0033126755     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199905000-00005     Document Type: Article

References (57)

1. Hill AG, Hill GL. Metabolic response to severe injury. Br J Surg 1998; 85:884-890.
2. DeBlaauw I, Deutz NEP, Von Meyenfeldt MF. Metabolic changes of cancer cachexia - first of two parts. Clin Nutr 1997; 16:169-176. .
3. DeBlaauw I, Deutz NEP, Von Meyenfeldt MF. Metabolic changes of cancer cachexia - second of two parts. Clin Nutr 1997; 16:223-228.
4. Argiles JM, Lopez-Soriano FJ. Catabolic proinflammatory cytokines. Clin Nutr Metab Care 1998; 1:245-251.
5. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst 1997; 89:1763-1773. This review examines the many factors implicated in cancer cachexia in considerable detail.
6. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ. Biological evaluation of a lipid mobilising factor isolated from the urine of cancer patients. Cancer Res 1998; 58:2359-2365.
7. Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 1997; 127:383-393.
8. Wigmore SJ, Fearon KCH, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci 1997; 92:215-221. This paper links the amelioration of cachexia by EPA to a reduction in the acute phase response and downregulation of IL-6 production.
9. Barber MD, Ross JA, Fearon KCH. n-3 Polyunsaturated fatty acids in the treatment of pancreatic cancer cachexia. In: Pancreatic disease - towards the year 2000, 2nd ed. Johnson CD, Imrie CW (editors). London: Springer; 1998. pp. 311-324. A detailed assessment of the use of PUFAs in treating cancer cachexia.
10. Sessler AM, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. J Nutr 1998; 128:923-926. An excellent review article on the PUFA regulation of gene expression, particularly in regard to adipocyte differentiation.
11. Miles EA, Calder PC. Modulation of immune function by dietary fatty acids. Proc Nutr Soc 1998; 57:277-292. A comprehensive review of the effects of fatty acids on immune function.
12. Jolly CA, Jiang Y-H, Chapkin RS, McMurray DN. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 1997; 127:37-43.
13. Escudero A, Montilla JC, Garcia JM, Aanchez-Quevedo MC, Periago JL, Hortelano P, Suarez MD. Effect of dietary (n-9), (n-6) and (n-3) fatty acids on membrane lipid composition and morphology of rat erythrocytes. Biochim Biophys Acta 1998; 1394:65-73.
14. Lai PBS, Ross JA. Modulation of adhesion molecule expression on tumour cell lines following exposure to the omega-3 fatty acid eicosapentaenoic acid. In: Leucocyte typing VI. Kishimoto T, Kikutani H, von dem Borne AEGKr, Goyert SM, Mason DY, Miyasaka L, et al. (editors). New York and London: Garland Publishing; 1997. pp. 360-361.
15. Seljiflot I, Amesen H, Brude IR, Nenseter MS, Drevon CA, Hjermann I. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest 1998; 28:629-635.
16. + channels by directly binding to the channel proteins. Proc Natl Acad Sci USA 1996; 93:3542-3546.
17. 2 distinct roles of cyclooxygenase-1 and -2. J Biol Chem 1997; 272:25693-25699.
18. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH. Dietary supplementation with γ-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr 1997; 127:1435-1444.
19. Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids - the n-6/n-3 balance and chronic elderly disease. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan. Prog Lipid Res 1997; 35:409-457.
20. Holman RT. Omega 3 and omega 6 essential fatty acid status in human health and disease. In: Handbook of essential fatty acid biology: biochemistry, physiology and behavioural neurobiology. Yehuda S, Mostofsky DI (editors). Totowa, NJ: Humana Press; 1997. pp. 139-182.
21. Lahoz C, Alonso R, Ordovas JM, Lopez-Farre A, De Oya M, Mata P. Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest 1997; 27:780-787.
22. Alexander JW. Immunonutrition: the role of ω-3 fatty acids. Nutrition 1998; 14:627-633. A succinct but detailed review of the mechanism of action of fatty acids and their uses in treating human disease.
23. Sanderson P, Calder PC. Dietary fish oil appears to prevent the activation of phospholipase C-γ in lymphocytes. Biochim Biophys Acta 1998; 1392:300-308.
24. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARχ). J Biol Chem 1998; 273:5678-5684.
25. 4 pathway to inflammation control. Nature 1996; 384:39-43.
26. Clarke SD, Jump D. Polyunsaturated fatty acids regulate lipogenic and peroxisomal gene expression by independent mechanisms. Prostaglandins Leukotrienes Essent Fatty Acids 1997; 57:65-69.
27. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, MaJd Z, et al. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998; 273:25573-25580.
28. Meydani SN. Effect of (n-3) polyunsaturated fatty acids on cytokine production and their biologic function. Nutrition 1996; 12:S8-14.
29. Lai PBS, Ross JA, Fearon KCH, Anderson JD, Carter DC. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 1996; 74:1375-1383.
30. Ghosh S, May MJ, Kopp EB. NFκB and Rel proteins: evolutionary conserved mediators of immune responses. Annu Rev Immunol 1998; 16:225-260. A comprehensive review of the biology of NFκB.
31. Hennig B, Toborek M, Joshi-Barve S, Barger SW, Barve S, Mattson MP, McClain CJ. Linoleic acid activates nuclear transcription factor-κB (NF-κB) and induces NF-κB-dependent transcription in cultured endothelial cells. Am J Clin Nutr 1996; 63:322-328.
32. Stuhlmeier KM, Kao JJ, Bach FH. Arachidonic acid influences proinflammatory gene induction by stabilizing the inhibitor-κBalpha/nuclear factor-κB (NF-κB) complex, thus suppressing the nuclear translocation of NF-κB. J Biol Chem 1997; 272:24679-24683.
33. Camandola S, Leonarduzzi G, Musso T, Varesio L, Carini R, Scavazza A, et al. Nuclear factor κB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun 1996; 229:643-647.
34. Worgall TS, Sturley SL, Seo T, Osborne TF, Deckelbaum RJ. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J Biol Chem 1998; 273:25537-25540.
35. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-340.
36. Shimomura I, Shimano H, Korn BS, Bashmakov Y, Horton JD. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem 1998; 273:35299-35306.
37. Waters KM, Miller CW, Ntambi JM. Localization of polyunsaturated fatty acid response region in stearoyl-CoA desaturase gene 1. Biochim Biophys Acta 1997; 1349:33-40.
38. Baldie G, Kaimakamis D, Rotondo D. Fatty acid modulation of cytokine release from human monocytic cells. Biochim Biophys Acta 1993; 1179:125-133.
39. Calder PC. n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997; 41:203-234.
40. Endres S, Ghorbani R, Kelley V et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-271.
41. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor and interleukin-1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996; 63:116-122.
42. Calder PC. Dietary fatty acids and the immune system. Nutr Rev 1998; 56:370-83.
43. Hughes DA, Southon S, Pinder AC. (n-3) Polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996; 126:603-610.
44. McCarter MD, Gentilini OD, Gomez ME, Daly JM. Preoperative oral supplement with immunonutrients in cancer patients. J Parenter Enter Nutr 1998; 22:206-211.
45. Mendez C, Jurkovich GJ, Garcia I, Davis D, Parker A, Maier RV. Effects of an immune-enhancing diet in critically injured patients. J Trauma 1997; 42:933-941.
46. Saffle JR, Wiebke G, Jennings K, Morris SE, Barton RG. Randomised trial of immune-enhancing enterai nutrition in burn patients. J Trauma 1997; 42:793-802.
47. Weimann A, Bastian L, Bischoff WE, Grotz M, Hansel M, Lotz J, et al. Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma. Nutrition 1998; 14:165-172.
48. Senkal M, Mumme A, Eickhoff U, Geier B, Spath G, Wulfert D, et al. Early postoperative enterai immunonutrition: clinical outcome and cost comparison analysis in surgical patients. Crit Care Med 1997; 25:1489-1496.
49. Kenler AS, Swails WS, Driscoll DF, DeMichele SJ, Daley B, Babineau TJ, et al. Early enteral feeding in postsurgical cancer patients. Ann Surg 1996; 223:316-333.
50. Tisdale MJ. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition 1996; 12 (Suppl.):S31-33.
51. Tisdale MJ. New cachexic factors. Clin Nutr Metab Care 1998; 1:253-256.
52. Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC, Fearon KCH. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996; 12 (Suppl.):S27-30.
53. Barber MD, Wigmore SJ, Ross JA, Fearon KCH. Eicosapentaenoic acid attenuates cachexia associated with advanced pancreatic cancer. Prostaglandins Leukotrienes Essent Fatty Acids 1997; 57:204.
54. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalised malignancy. Cancer 1998; 82:395-402.
55. Hellerstein MK, Wu K, McGrath M, Faix D, George D, Shackleton CH, et al. Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immune deficiency syndrome: relation to indices of cytokine production. J Acquired Immune Defic Syndr Human Retrovirol 1996; 11:258-270.
56. Barber MD, Voss AC, Ross JA, Tisdale MJ, Fearon KCH. The effect of an eicosapentaenoic acid enriched nutritional supplement in weight-losing patients with advanced pancreatic cancer. Br J Cancer (in press).
57. Barber MD, Ross JA, McMillan DC, Preston T, Shenkin A, Fearon KCH. A fish oil enriched nutrition supplement modulates changes in the acute phase protein response in weight losing pancreatic cancer patients. Clin Nutr 1998; 17 (Suppl. 1):41.